Nevertheless, this differential mutational profile suggests that IKKα signalling may be occurring through two independent mechanisms, one which is associated with AR mutation and the other which is associated with alterations in KRAS and inferior survival outcomes in primary colorectal cancer. The gene discussed is CHUK; the disease is colorectal cancer.